149 related articles for article (PubMed ID: 37267252)
1. Rho-associated protein kinase 1 inhibition in hepatocytes attenuates nonalcoholic steatohepatitis.
Dohnalkova E; Bayer RL; Guo Q; Bamidele AO; Kim Lee HS; Valenzuela-Pérez L; Krishnan A; Pavelko KD; Guisot NES; Bunyard P; Kim YB; Ibrahim SH; Gores GJ; Hirsova P
Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37267252
[TBL] [Abstract][Full Text] [Related]
2. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
[TBL] [Abstract][Full Text] [Related]
3. Integrin β
Guo Q; Furuta K; Lucien F; Gutierrez Sanchez LH; Hirsova P; Krishnan A; Kabashima A; Pavelko KD; Madden B; Alhuwaish H; Gao Y; Revzin A; Ibrahim SH
J Hepatol; 2019 Dec; 71(6):1193-1205. PubMed ID: 31433301
[TBL] [Abstract][Full Text] [Related]
4. Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition.
Huang H; Lee SH; Sousa-Lima I; Kim SS; Hwang WM; Dagon Y; Yang WM; Cho S; Kang MC; Seo JA; Shibata M; Cho H; Belew GD; Bhin J; Desai BN; Ryu MJ; Shong M; Li P; Meng H; Chung BH; Hwang D; Kim MS; Park KS; Macedo MP; White M; Jones J; Kim YB
J Clin Invest; 2018 Dec; 128(12):5335-5350. PubMed ID: 30226474
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis.
Mauer AS; Hirsova P; Maiers JL; Shah VH; Malhi H
Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G300-G313. PubMed ID: 28039158
[TBL] [Abstract][Full Text] [Related]
6. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
7. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
9. CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis.
Tomita K; Freeman BL; Bronk SF; LeBrasseur NK; White TA; Hirsova P; Ibrahim SH
Sci Rep; 2016 Jun; 6():28786. PubMed ID: 27349927
[TBL] [Abstract][Full Text] [Related]
10. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis, steatohepatitis, and fibrosis in male mice.
Upadhyay KK; Choi EK; Foisner R; Omary MB; Brady GF
Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G184-G195. PubMed ID: 37366543
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis.
Hirsova P; Bohm F; Dohnalkova E; Nozickova B; Heikenwalder M; Gores GJ; Weber A
Cell Death Dis; 2020 Feb; 11(2):80. PubMed ID: 32015322
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
14. Modulating sphingosine 1-phosphate receptor signaling skews intrahepatic leukocytes and attenuates murine nonalcoholic steatohepatitis.
Liao CY; Barrow F; Venkatesan N; Nakao Y; Mauer AS; Fredrickson G; Song MJ; Sehrawat TS; Dasgupta D; Graham RP; Revelo XS; Malhi H
Front Immunol; 2023; 14():1130184. PubMed ID: 37153573
[TBL] [Abstract][Full Text] [Related]
15. CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis.
Lei Z; Yu J; Wu Y; Shen J; Lin S; Xue W; Mao C; Tang R; Sun H; Qi X; Wang X; Xu L; Wei C; Wang X; Chen H; Hao P; Yin W; Zhu J; Li Y; Wu Y; Liu S; Liang H; Chen X; Su C; Zhou S
J Hepatol; 2024 Feb; 80(2):194-208. PubMed ID: 38438948
[TBL] [Abstract][Full Text] [Related]
16. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages.
Tao L; Yi Y; Chen Y; Zhang H; Orning P; Lien E; Jie J; Zhang W; Xu Q; Li Y; Ding Z; Wu C; Ding Q; Wang J; Zhang J; Weng D
Cell Death Differ; 2021 Apr; 28(4):1418-1433. PubMed ID: 33208891
[TBL] [Abstract][Full Text] [Related]
17. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
Elife; 2023 Jan; 12():. PubMed ID: 36648330
[TBL] [Abstract][Full Text] [Related]
18. Protective and Detrimental Roles of p38α Mitogen-Activated Protein Kinase in Different Stages of Nonalcoholic Fatty Liver Disease.
Hwang S; Wang X; Rodrigues RM; Ma J; He Y; Seo W; Park SH; Kim SJ; Feng D; Gao B
Hepatology; 2020 Sep; 72(3):873-891. PubMed ID: 32463484
[TBL] [Abstract][Full Text] [Related]
19. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
[TBL] [Abstract][Full Text] [Related]
20. The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression.
Wang G; Duan J; Pu G; Ye C; Li Y; Xiu W; Xu J; Liu B; Zhu Y; Wang C
Biochim Biophys Acta Mol Basis Dis; 2022 Aug; 1868(8):166413. PubMed ID: 35413401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
